NTES-S
09999
TRIP.COM-S
09961
JD HEALTH
06618
BOSS ZHIPIN-W
02076
TME-SW
01698
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 19.31%463.08M | -36.00%208.5M | -76.05%60.54M | -58.42%459.43M | -54.40%388.12M | -45.34%325.79M | -16.86%252.78M | -2.85%1.1B | 3.11%851.05M | 3.29%596.02M |
Operating income | 19.31%463.08M | -36.00%208.5M | -76.05%60.54M | -58.42%459.43M | -54.40%388.12M | -45.34%325.79M | -16.86%252.78M | -2.85%1.1B | 3.11%851.05M | 3.29%596.02M |
Cost of sales | -30.23%-398.31M | 16.87%-190.55M | 52.00%-72.04M | 46.56%-379.07M | 44.60%-305.85M | 38.51%-229.23M | 24.40%-150.07M | 3.25%-709.39M | -3.59%-552.12M | -1.49%-372.8M |
Operating expenses | -30.23%-398.31M | 16.87%-190.55M | 52.00%-72.04M | 46.56%-379.07M | 44.60%-305.85M | 38.51%-229.23M | 24.40%-150.07M | 3.25%-709.39M | -3.59%-552.12M | -1.49%-372.8M |
Gross profit | -21.28%64.77M | -81.41%17.95M | -111.19%-11.5M | -79.68%80.37M | -72.48%82.27M | -56.74%96.56M | -2.67%102.71M | -2.12%395.56M | 2.25%298.93M | 6.45%223.22M |
Administrative expenses | -2.80%-29.69M | -12.96%-19.75M | 5.09%-9.1M | 26.30%-38.95M | 16.19%-28.88M | 4.19%-17.48M | 3.67%-9.58M | -20.06%-52.85M | -23.71%-34.46M | 0.81%-18.24M |
Research and development expenses | 3.01%-7.6M | 52.33%-2.9M | 83.05%-787K | 65.68%-8.71M | 58.10%-7.84M | 46.42%-6.08M | 21.12%-4.64M | 4.05%-25.37M | -16.27%-18.71M | -19.84%-11.36M |
Special items of operating profit | 45.58%-191K | -77.50%-142K | -162.86%-92K | -55.32%-744K | 6.90%-351K | 72.97%-80K | 12.50%-35K | 33.29%-479K | -4.72%-377K | -196.00%-296K |
Operating profit | -39.64%27.28M | -106.64%-4.84M | -124.28%-21.47M | -89.91%31.96M | -81.58%45.2M | -62.28%72.92M | -1.34%88.45M | -4.84%316.86M | -1.07%245.38M | 6.38%193.32M |
Financing income | -11.78%5.2M | -35.69%3.79M | -41.50%1.23M | -22.65%7.03M | -33.52%5.9M | -12.39%5.9M | 156.92%2.1M | 41.74%9.09M | 126.01%8.87M | 91.58%6.73M |
Financing cost | 11.62%-17.08M | 16.20%-11.39M | 15.55%-5.66M | 18.75%-24.97M | 18.24%-19.32M | 15.78%-13.59M | 18.10%-6.71M | 15.35%-30.74M | 15.64%-23.64M | 16.62%-16.13M |
Special items of earning before tax | 74.21%-7.73M | 67.55%-10.05M | -115.23%-504K | -63.89%-32.69M | -15.47%-29.97M | -213.93%-30.98M | 97.85%3.31M | -332.43%-19.95M | -498.62%-25.95M | -247.92%-9.87M |
Earning before tax | 325.25%7.68M | -165.66%-22.49M | -130.30%-26.41M | -106.78%-18.67M | -99.12%1.81M | -80.32%34.25M | 3.81%87.15M | -11.67%275.26M | -11.19%204.66M | 0.86%174.06M |
Tax | -47.31%-10.7M | 5.82%-8.41M | 104.26%362K | 91.38%-4.3M | 73.86%-7.26M | 56.52%-8.93M | 30.13%-8.49M | -16.03%-49.86M | -35.18%-27.78M | -37.77%-20.53M |
After-tax profit from continuing operations | 44.68%-3.02M | -222.00%-30.89M | -133.12%-26.05M | -110.19%-22.97M | -103.09%-5.46M | -83.51%25.32M | 9.55%78.66M | -16.11%225.4M | -15.73%176.88M | -2.62%153.53M |
Earning after tax | 44.68%-3.02M | -222.00%-30.89M | -133.12%-26.05M | -110.19%-22.97M | -103.09%-5.46M | -83.51%25.32M | 9.55%78.66M | -16.11%225.4M | -15.73%176.88M | -2.62%153.53M |
Minority profit | -28.31%1.53M | -36.78%782K | -71.48%251K | -4.78%2.53M | 63.88%2.14M | 12.05%1.24M | 53.58%880K | 102.28%2.66M | 21.64%1.3M | 35.96%1.1M |
Profit attributable to shareholders | 40.07%-4.55M | -231.51%-31.67M | -133.81%-26.3M | -111.45%-25.5M | -104.33%-7.59M | -84.20%24.08M | 9.20%77.78M | -16.69%222.74M | -15.92%175.58M | -2.82%152.42M |
Basic earnings per share | 40.10%-0.0115 | -231.41%-0.0799 | -133.79%-0.0663 | -111.44%-0.0643 | -104.34%-0.0192 | -84.19%0.0608 | 9.18%0.1962 | -16.68%0.5619 | -15.93%0.4429 | -2.83%0.3845 |
Diluted earnings per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.